Procainamide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Procainamide and local guidelines before prescribing.

Class Ia antiarrhythmic

Mechanism

Class Ia sodium-channel blocker.

Uses

Ventricular arrhythmia, pre-excited AF (alternative).

Dosing

2 more dose entries from the chapters
  • Amiodarone Stable monomorphic VT alternative | 300 mg IV over 10–60 min, then 900 mg IV over 24 h when procainamide unsuitable and expert advice supports.
    Cardiology: Cardiac Arrhythmias
  • Procainamide Selected VT | 10–15 mg/kg IV over 20 min (maximum 1 g); specialist monitoring, local availability and contraindications matter.
    Cardiology: Cardiac Arrhythmias

Side effects

Hypotension, QT prolongation, drug-induced lupus, agranulocytosis.

Interactions

Amiodarone and QT-prolonging drugs increase proarrhythmia.

Contraindications and cautions

Heart block, SLE, long QT

Monitoring

ECG, BP, ANA, FBC

Pregnancy and breastfeeding

Use if essential

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive; sodium bicarbonate

Special advice

Slow IV infusion with BP monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book